Lundbeck to pay billions for Irish sleep drug

The Danish pharmaceutical company Lundbeck has made a multi-billion-dollar bid for the Irish company Avadel, confirmed in a stock exchange announcement. Lundbeck’s bid is valued up to $2.25 billion, approximately 14.5 billion Danish kroner. Avadel has developed Lumryz, a drug to combat...